Resistance gene profiling of beta-lactamase and carbapenemase in gram-negative blood isolates: A tertiary care hospital
PLOS One · 30.03.2026 · 21 (3) · e0344856
DOI: 10.1371/journal.pone.0344856 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.03.2026. Verfasst von Daniel Beshah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, School of Biomedical and Laboratory Science, College of Health Sciences, Addis Ababa University, Addis Abab…. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Gram-Negative Bacteria. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was funded by the Addis Ababa University vice president for research and technology transfer office thematic research funding program.
Abstract (Originalsprache)
The global rise in antimicrobial resistance is largely driven by DNA-encoded, antibiotic-hydrolyzing enzymes. This study aimed to determine the prevalence of ESBL, AmpC-BL, MBL, and carbapenemase genes. A cross-sectional study was conducted from September 2018 to March 2019 using standard microbiological and molecular methods. Among 231 Gram-negative bacterial isolates, 176 (76.2%) carried beta-lactamase genes confirmed by PCR. ESBLs were detected in 117 (50.6%), MBLs in 50 (21.6%), carbapenemases in 46 (19.9%), and AmpC-BLs in 22 (9.5%). The most frequent carriers were Klebsiella pneumoniae , Escherichia coli , and Acinetobacter species . The dominant ESBL genes were blaCTX-M (85.2%) and blaTEM (79.5%), with blaBEL (17.2%) surpassing blaSHV (9.8%), indicating a shift in resistance patterns, while among AmpC genes, blaFOX (39.4%) and blaCITM (36.4%) were the most prevalent. The blaOXA-23 (40.6%) and blaKPC (14.5%) were the most common carbapenemase genes, while blaNDM (39.1%) and blaVIM (34.8%) dominated among MBLs. The high prevalence of blaOXA-23 in Ethiopia is a significant finding, which I have not found evidence of in similar African or Asian settings. A comparable trend in Taiwan suggests medical tourism may contribute to the spread of resistant bacteria. These findings highlight the critical importance of continuous molecular surveillance and indicate that factors like medical tourism may contribute to the international dissemination of resistant strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Science, School of Biomedical and Laboratory Science, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Institute of Biotechnology, Addis Ababa University, Addis Ababa, Ethiopia.
- Department of Microbial, Cellular, and Molecular Biology, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
- Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
- Department of Medical Laboratory Science, Debre Berhan University, Debre Berhan, Ethiopia.
ORCID-Profile: Daniel Beshah, Adey Feleke Desta
Förderung
- This work was funded by the Addis Ababa University vice president for research and technology transfer office thematic research funding program
Zitieren
APA
Beshah, D., Tessema, T. S., Woldemichael, G. B., Belachew, E. B., Alemayehu, D. H., Tesfaye, A., Tefera, D. A., Derese, S. G., Zelelie, T. Z., Admasie, A., Abebe, T., & Desta, A. F. (2026). Resistance gene profiling of beta-lactamase and carbapenemase in gram-negative blood isolates: A tertiary care hospital. PLOS One, 21(3), e0344856. https://doi.org/10.1371/journal.pone.0344856
Vancouver
Beshah D, Tessema TS, Woldemichael GB, Belachew EB, Alemayehu DH, Tesfaye A, et al. Resistance gene profiling of beta-lactamase and carbapenemase in gram-negative blood isolates: A tertiary care hospital. PLOS One. 2026;21(3):e0344856. doi:10.1371/journal.pone.0344856
BibTeX
@article{Beshah2026,
author = {Beshah, Daniel and Tessema, Tesfaye Sisay and Woldemichael, Gurja Belay and Belachew, Esmael Besufikad and Alemayehu, Dawit Hailu and Tesfaye, Abebech and Tefera, Dessalegn Abeje and Derese, Solomon Gizaw and Zelelie, Tizazu Zenebe and Admasie, Abera and Abebe, Tamrat and Desta, Adey Feleke},
title = {Resistance gene profiling of beta-lactamase and carbapenemase in gram-negative blood isolates: A tertiary care hospital},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {3},
pages = {e0344856},
doi = {10.1371/journal.pone.0344856}
}
EUVIMED